According to Zacks, “BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel. “
BWAY opened at $8.53 on Monday. The business has a 50 day moving average of $9.65. BRAINSWAY LTD/S has a 1 year low of $8.00 and a 1 year high of $12.39.
A number of hedge funds have recently made changes to their positions in BWAY. Victory Capital Management Inc. acquired a new position in BRAINSWAY LTD/S during the second quarter valued at approximately $157,000. Noked Capital LTD acquired a new position in shares of BRAINSWAY LTD/S during the second quarter worth $572,000. ARK Investment Management LLC acquired a new position in shares of BRAINSWAY LTD/S during the second quarter worth $863,000. Finally, Delek Group Ltd. acquired a new position in shares of BRAINSWAY LTD/S during the second quarter worth $3,176,000. 10.84% of the stock is currently owned by hedge funds and other institutional investors.
BRAINSWAY LTD/S Company Profile
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.
Featured Article: Hold Rating
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.